Can the process compressed air in pharmaceutical factories use micro-oil air compressors?

Compliance Analysis of Micro-oil Air Compressor Used for Process Compressed Air in Pharmaceutical Factory

the quality requirements of compressed air in pharmaceutical production are extremely stringent, which requires a comprehensive assessment from the three dimensions of pollution control, regulatory compliance and process suitability. The following is a professional analysis based on industry norms and technical practices:

1. drug production quality risk

1. oil pollution risk
   micro-oil air compressor realizes bearing lubrication and sealing through lubricating oil, but oil may be generated during operation. Experimental data show that even under ideal conditions, the exhaust oil content may still reach 0.01-0.1mg/ m³. Such oils may enter the process as aerosols or vapors, with the following risks:

• drug contamination: Chemical reaction between oil and drug components, resulting in degradation of active ingredients or unknown impurities.
• Equipment corrosionoil deposits on the inner wall of the pipeline, breeding microorganisms and forming biofilm, increasing the risk of contamination of the process system.
• Product Recall: In the production of sterile preparations, oil contamination may trigger excessive microbial limits, resulting in the entire batch of products scrapped.

2. Particulate Matter Control Challenges
   the micro-oil air compressor needs to be equipped with a multi-stage filtration system to reduce the oil content, but the filter has the risk of penetration. For example, if the front-end filtration efficiency is insufficient, the rear-end precision filter may fail prematurely due to excessive load, resulting in a breakthrough of particulate matter.

2. regulatory and industry code requirements

1. international Standard Constraints
   according to ISO 8573 Compressed Air, compressed air for pharmaceutical production shall meet the following requirements:

• oil content:≤0.01mg/ m³ (Class 1 grade), and the micro-oil air compressor is difficult to reach the standard stably.
• Particulate matter: ≤ 0.1μm particle size (Class 1), to be achieved by high efficiency filter.

2. Drug Regulatory Requirements
   china GMP Appendix “Sterile Drugs” clearly requires:

• compressed air in direct contact with the drug must be sterilised and filtered, and the integrity of the filter must be tested regularly.
• Compressed air used in the production of non-sterile drugs needs to control the microbial load and prevent cross-contamination.

3. Process Adaptability Analysis

1. high risk process disabled
   the use of micro-oil air compressors is strictly prohibited in the following scenarios:

• sterile preparation productionsuch as injection, freeze-dried powder needle, oil may destroy the sterile barrier.
• Inhalation preparation production: Oil may be deposited on the surface of the atomized particles, affecting the drug delivery dose.
• fermentation of biological products: Oil inhibits microbial metabolism, resulting in a decrease in fermentation efficiency.

2. Low risk process used with caution
   if a micro-oil air compressor is required in the following scenarios, the following requirements shall be met:

• configuration of three-stage filtration system (front-end degreasing + middle-end dedusting + end sterilization).
• Install an online oil detector to monitor the oil content in real time.
• Annual filter integrity testing and compressed air quality audits.

4. Alternatives and Technology Path

1. oil-free air compressor
   adopt water-lubricated or oil-free screw technology to eliminate the risk of oil contamination at the source. Such devices have implemented:

• oil content ≤ 0.003mg/ m³, much lower than the micro-oil model.
• Maintenance costs are reduced by 30%, as there is no need to replace the oil filter.

2. Transformation of Micro-oil Air Compressor
   if micro-oil equipment has been installed, it can be degraded by the following measures:

• add activated carbon adsorption device to remove gaseous oil.
• Shorten the filter replacement cycle to ensure filtration efficiency ≥ 99.999%.
• Establish a compressed air quality monitoring plan, sampling and testing every quarter.

Conclusion
pharmaceutical plant process compressed airshould not use micro oil air compressorespecially in high-risk processes that come into direct contact with drugs. If it needs to be used for special reasons, the risk must be controlled within an acceptable range through multiple filtering, online monitoring, regular audit and other measures. It is suggested that oil-free air compressor should be preferred and equipped with efficient purification system to ensure drug quality and patient safety.